The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.

However, not all companies with momentum are long-term winners, and many investors have lost money by following short-term trends. All that said, here is one stock we think lives up to the hype and two best left ignored.

Two Stocks to Sell:

Masimo (MASI)

One-Month Return: +1.6%

Founded in 1989 to solve the "unsolvable problem" of accurate pulse oximetry during patient movement, Masimo (NASDAQ: MASI) develops and manufactures noninvasive patient monitoring technologies, including its breakthrough pulse oximetry systems that accurately measure blood oxygen levels even during patient movement.

Why Do We Think Twice About MASI?

1. Sales tumbled by 16.3% annually over the last two years, showing market trends are working against its favor during this cycle
2. Revenue base of $1.48 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale
3. Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions

Masimo’s stock price of $178.13 implies a valuation ratio of 31.1x forward P/E. If you’re considering MASI for your portfolio, see our FREE research report to learn more.

Bunge Global (BG)

One-Month Return: +0.2%

With origins dating back to 1818 and operations spanning both hemispheres to balance seasonal harvests, Bunge Global (NYSE: BG) is an agribusiness and food company that processes oilseeds, grains, and other agricultural commodities into vegetable oils, protein meals, flours, and specialty ingredients.

Why Does BG Fall Short?

1. Annual sales growth of 1.5% over the last three years lagged behind its consumer staples peers as its large revenue base made it difficult to generate incremental demand
2. Performance over the past three years shows its incremental sales were much less profitable, as its earnings per share fell by 19.1% annually
3. Limited cash reserves may force the company to seek unfavorable financing terms that could dilute shareholders

Bunge Global is trading at $121.52 per share, or 14.9x forward P/E. To fully understand why you should be careful with BG, check out our full research report (it’s free).

One Stock to Watch:

Altria (MO)

One-Month Return: -6%

Best known for its Marlboro brand of cigarettes, Altria (NYSE: MO) offers tobacco and nicotine products.

Why Could MO Be a Winner?

1. Unique products and pricing power result in a best-in-class gross margin of 71.1%
2. Disciplined cost controls and effective management resulted in a strong two-year operating margin of 52.1%
3. Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends, and its expanding margin gives it even more flexibility

At $64.82 per share, Altria trades at 11.6x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.